← Eichor
Condition: Hcl Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Hcl

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Clinical Study of Fasudil Hydrochloride and PD1 Inhibitor Combined With Androgen Deprivation in Neoadjuvant Therapy of P
Phase 2/Phase 3 · 1 location(s) · baotai Liang · NCT06861192A Multicenter, Open-label, Single-arm, Phase II Study of NHWD-870 HCl in Adults and Adolescents with Advanced NUT Cancer
Phase 2 · 1 location(s) · Zhejiang Wenda Pharma Technology LTD. · NCT06527300Chemotherapy Combined With Propranolol Hydrochloride as Neoadjuvant Therapy for Advanced High-grade Serous Ovarian Cance
Phase 2 · 1 location(s) · Bai-Rong Xia · NCT07125391TIzanidine for the Preventive Treatment of Episodic MigrainE （TIME）
Phase 3 · 6 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT05484349Iparomlimab and Tuvonralimab Combined With Apatinib and Irinotecan Hydrochloride for the Treatment of Advanced Alpha-fet
Phase 2 · 1 location(s) · Hebei Medical University Fourth Hospital · NCT07289997A Clinical Study on the Efficacy and Safety of Fasudil Hydrochloride Combined With Immunotherapy in the Treatment of Met
Phase 2 · 1 location(s) · baotai Liang · NCT07250542Dextromethorphan-Bupropion on Striatal Activity in Adults With Major Depressive Disorder
Phase 2 · 1 location(s) · Roger McIntyre · NCT07523048Gemcitabine Hydrochloride, Cisplatin, Nab-Paclitaxel, and Durvalumab in Treating Patients With Locally Advanced or Metas
Phase 2 · 1 location(s) · Fudan University · NCT06591650T1D Pregnancy & Me
Phase N/A · 10 location(s) · Jaeb Center for Health Research · NCT06959316Magnesium Supplementation in Advanced Non-small Cell Lung Cancer (NSCLC)
Phase 2/Phase 3 · 11 location(s) · Swiss Cancer Institute · NCT07149649Zeprumetostat, Azacitidine Combined With Lipo-MIT in R/R PTCL
Phase 2 · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT07372352AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas
Phase 1 · 1 location(s) · Stanford University · NCT06340737Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
Phase 1 · 4 location(s) · Newave Pharmaceutical Inc · NCT04775745Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Su
Phase 4 · 1 location(s) · University of South Florida · NCT02630121A Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Characteristics of (R)-Ketamine Hydrochloride Nasal Spray
Phase 2 · 8 location(s) · Sichuan Purity Pharmaceutical Technology Co., Ltd. · NCT07193901GVM±R in Patients With Relapsed or Refractory Aggressive NHL.
Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06244368Bariatric Surgery and Pharmacokinetics of Venlafaxine
Phase N/A · 1 location(s) · Norwegian University of Science and Technology · NCT03532477Effect of Quinine Hydrochloride in Overweight Population on Food Intake, Hunger and Gut Peptide Release
Phase 1 · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT04873011LIDRISE Study: A Phase 3 Study on the Efficacy and Safety of STN1013800 (Oxymetazoline HCl 0.1% Eye Drops, Single Dose)
Phase 3 · 36 location(s) · Santen SAS · NCT06514612Treatment of Irinotecan Hydrochloride Liposome Injection II in China: a Real World Study of Pancreatic Cancer Patients
Phase N/A · 10 location(s) · Peking Union Medical College Hospital · NCT06375473Mitoxantrone Hydrochloride Liposome in Combination With Cytarabine and Venetoclax Regimen in Newly Diagnosed Elderly AML
Phase 2 · 1 location(s) · First Affiliated Hospital of Zhejiang University · NCT06621199The Evaluation of the Effectiveness and Safety of Nalbuphine Hydrochloride Injection for Analgesia in ICU Patients: A Mu
Phase 2/Phase 3 · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT06785571Safety and Efficacy of Mitoxantrone Hydrochloride Liposome Based DCMG Regimen for R/R AML
Phase 2 · 1 location(s) · Beijing 302 Hospital · NCT06741722Decoding the Extracellular Vesicles-driven Communication in the Microenvironment of Hairy Cell Leukemia to Improve Patie
Phase N/A · 3 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06774677The Impact of Fexofenadine Hydrochloride on the Prognosis of Patients Post-Acute Myocardial Infarction
Phase 3 · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT07381803A Phase I Clinical Trial to Evaluate the Pharmacokinetic Characteristics of Ammoxetine Hydrochloride Enteric-Coated Tabl
Phase 1 · 1 location(s) · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · NCT07694869Hairy Cell Leukemia Patient Data Registry
Phase N/A · 8 location(s) · Ohio State University Comprehensive Cancer Center · NCT02560883Comparison of DW-1021 and Separate Doses of Pelubi CR and Zytram CR Under Fasting Conditions
Phase 1 · 2 location(s) · Haiphong University of Medicine and Pharmacy · NCT07032558Sonodynamic Therapy With SONALA-001 or 5-ALA HCL and Magnetic Resonance Guided Focused Ultrasound for the Treatment of P
EARLY_Phase 1 · 1 location(s) · Mayo Clinic · NCT07076472Dose-escalation Study of D-CMG Regimen for the Treatment of Elderly Newly Diagnosed AML Patients
Phase 1 · 1 location(s) · The First Affiliated Hospital of Xiamen University · NCT06651866
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.